agent: cause edema

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents biological agent
Weight: 0.76
, real estate agent
Weight: 0.65
, source
Weight: 0.64
, contractor
Weight: 0.62
Siblings travel agent
Weight: 0.75
, representative
Weight: 0.67
, beta blocker
Weight: 0.65
, solicitor
Weight: 0.63
, attorney
Weight: 0.62

Related properties

Property Similarity
cause edema 1.00
cause pulmonary edema 0.94
be contraindicated in edema 0.89
be contraindicated in pulmonary edema 0.88
cause vasodilation 0.83
cause hyperkalemia 0.82
cause hyperglycemia 0.81
cause hypoglycemia 0.80
be used in esophageal varices 0.80
cause muscle pain 0.79

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.09
Rule weight: 0.13
Evidence weight: 0.68
Similarity weight: 1.00
Evidence: 0.36
¬ Remarkable(agent, cause edema) ⋁
Evidence: 0.89
¬ Remarkable(beta blocker, cause edema)
0.09
Rule weight: 0.13
Evidence weight: 0.73
Similarity weight: 0.88
Evidence: 0.36
¬ Remarkable(agent, cause edema) ⋁
Evidence: 0.75
¬ Remarkable(beta blocker, be contraindicated in pulmonary edema)
0.08
Rule weight: 0.13
Evidence weight: 0.74
Similarity weight: 0.80
Evidence: 0.36
¬ Remarkable(agent, cause edema) ⋁
Evidence: 0.72
¬ Remarkable(beta blocker, cause hypoglycemia)
0.08
Rule weight: 0.13
Evidence weight: 0.74
Similarity weight: 0.80
Evidence: 0.36
¬ Remarkable(agent, cause edema) ⋁
Evidence: 0.73
¬ Remarkable(beta blocker, be used in esophageal varices)
0.08
Rule weight: 0.13
Evidence weight: 0.71
Similarity weight: 0.83
Evidence: 0.36
¬ Remarkable(agent, cause edema) ⋁
Evidence: 0.81
¬ Remarkable(beta blocker, cause vasodilation)
0.08
Rule weight: 0.13
Evidence weight: 0.69
Similarity weight: 0.82
Evidence: 0.36
¬ Remarkable(agent, cause edema) ⋁
Evidence: 0.86
¬ Remarkable(beta blocker, cause hyperkalemia)

Remarkability from sibling implausibility

0.59
Rule weight: 0.60
Evidence weight: 0.98
Similarity weight: 1.00
Evidence: 0.41
Plausible(agent, cause edema) ⋁
Evidence: 0.89
Remarkable(beta blocker, cause edema) ⋁
Evidence: 0.38
¬ Plausible(beta blocker, cause edema)
0.49
Rule weight: 0.60
Evidence weight: 0.91
Similarity weight: 0.88
Evidence: 0.41
Plausible(agent, cause edema) ⋁
Evidence: 0.75
Remarkable(beta blocker, be contraindicated in pulmonary edema) ⋁
Evidence: 0.60
¬ Plausible(beta blocker, be contraindicated in pulmonary edema)
0.48
Rule weight: 0.60
Evidence weight: 0.96
Similarity weight: 0.82
Evidence: 0.41
Plausible(agent, cause edema) ⋁
Evidence: 0.86
Remarkable(beta blocker, cause hyperkalemia) ⋁
Evidence: 0.45
¬ Plausible(beta blocker, cause hyperkalemia)
0.47
Rule weight: 0.60
Evidence weight: 0.95
Similarity weight: 0.83
Evidence: 0.41
Plausible(agent, cause edema) ⋁
Evidence: 0.81
Remarkable(beta blocker, cause vasodilation) ⋁
Evidence: 0.42
¬ Plausible(beta blocker, cause vasodilation)
0.45
Rule weight: 0.60
Evidence weight: 0.94
Similarity weight: 0.80
Evidence: 0.41
Plausible(agent, cause edema) ⋁
Evidence: 0.73
Remarkable(beta blocker, be used in esophageal varices) ⋁
Evidence: 0.39
¬ Plausible(beta blocker, be used in esophageal varices)
0.43
Rule weight: 0.60
Evidence weight: 0.90
Similarity weight: 0.80
Evidence: 0.41
Plausible(agent, cause edema) ⋁
Evidence: 0.72
Remarkable(beta blocker, cause hypoglycemia) ⋁
Evidence: 0.64
¬ Plausible(beta blocker, cause hypoglycemia)

Salient implies Plausible

0.22
Rule weight: 0.28
Evidence weight: 0.80
Similarity weight: 1.00
Evidence: 0.41
Plausible(agent, cause edema) ⋁
Evidence: 0.35
¬ Salient(agent, cause edema)

Similarity expansion

0.69
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.94
Evidence: 0.36
Remarkable(agent, cause edema) ⋁
Evidence: 0.22
¬ Remarkable(agent, cause pulmonary edema)
0.66
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.94
Evidence: 0.35
Salient(agent, cause edema) ⋁
Evidence: 0.27
¬ Salient(agent, cause pulmonary edema)
0.63
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.94
Evidence: 0.41
Plausible(agent, cause edema) ⋁
Evidence: 0.37
¬ Plausible(agent, cause pulmonary edema)
0.58
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.94
Evidence: 0.53
Typical(agent, cause edema) ⋁
Evidence: 0.59
¬ Typical(agent, cause pulmonary edema)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.88
Similarity weight: 1.00
Evidence: 0.35
Salient(agent, cause edema) ⋁
Evidence: 0.53
¬ Typical(agent, cause edema) ⋁
Evidence: 0.36
¬ Remarkable(agent, cause edema)

Typical implies Plausible

0.33
Rule weight: 0.48
Evidence weight: 0.69
Similarity weight: 1.00
Evidence: 0.41
Plausible(agent, cause edema) ⋁
Evidence: 0.53
¬ Typical(agent, cause edema)

Typicality and Rermarkability incompatibility between siblings

0.13
Rule weight: 0.14
Evidence weight: 0.93
Similarity weight: 1.00
Evidence: 0.36
¬ Remarkable(agent, cause edema) ⋁
Evidence: 0.21
¬ Typical(beta blocker, cause edema)
0.10
Rule weight: 0.14
Evidence weight: 0.88
Similarity weight: 0.83
Evidence: 0.36
¬ Remarkable(agent, cause edema) ⋁
Evidence: 0.33
¬ Typical(beta blocker, cause vasodilation)
0.10
Rule weight: 0.14
Evidence weight: 0.88
Similarity weight: 0.82
Evidence: 0.36
¬ Remarkable(agent, cause edema) ⋁
Evidence: 0.33
¬ Typical(beta blocker, cause hyperkalemia)
0.10
Rule weight: 0.14
Evidence weight: 0.88
Similarity weight: 0.80
Evidence: 0.36
¬ Remarkable(agent, cause edema) ⋁
Evidence: 0.34
¬ Typical(beta blocker, be used in esophageal varices)
0.10
Rule weight: 0.14
Evidence weight: 0.79
Similarity weight: 0.88
Evidence: 0.36
¬ Remarkable(agent, cause edema) ⋁
Evidence: 0.58
¬ Typical(beta blocker, be contraindicated in pulmonary edema)
0.08
Rule weight: 0.14
Evidence weight: 0.77
Similarity weight: 0.80
Evidence: 0.36
¬ Remarkable(agent, cause edema) ⋁
Evidence: 0.64
¬ Typical(beta blocker, cause hypoglycemia)